This module includes the mechanism of nociception and multimodal therapy as well as opioids and adjuvants used in multimodal therapy.

This module includes patient care priorities for the Parkinson’s patient.

This module includes the etiology, rick factors, incidence, signs & symptoms, and treatment for PTSD/PTSS.

This module includes preprocedural assessment, intraoperative positioning, possible complications & interventions and patient teaching.

This module includes strategies for to handle crucial conversations in stressful situations.

This module includes the ASPAN perianesthesia standards, practice recommendations, position statements and their application to practice.

ASPAN Perianesthesia Certification Review Bundle
(Requirements for Successful Completion: You must view each module it its entirety, achieve a 100% on the post test, and complete the online evaluation by the deadline to receive continuing nursing education, contact hour credit.)  The PCR Bundle is available to you for 60 days from your date of purchase.

The Perianesthesia Certification Review bundle is a great resource for starting your review for both the perianesthesia certification exams, CPAN® & CAPA®, offered by the American Board of Perianesthesia Nursing Certification. This is a "Learner Paced" educational activity.

1. Overview of the Perianesthesia Certification Exams (1.0 CH, IC) 
2. Anesthetic Agents and Techniques (2.5 CH, DC) 
3. Special Populations (2.0 CH, DC) 
4. ASPAN Standards (1.75 CH, DC) 
5. Clinical Judgement in Perianesthesia Nursing (1.25 CH, IC) 
6. Test Taking Tips (1.0 CH, IC) 

This module includes anesthesia techniques and commonly used anesthetic agents.

This module includes special anatomical and physiological considerations unique to the pediatric, geriatric and pregnant patient.

Authors: Edwin N. Aroke, PhD, CRNA, Alexis N. Robinson, MSN, APRN, CRNA, Bryan A. Wilbanks, PhD, DNP, CRNA
In the United States, approximately 15% of adults suffer from major depressive disorder (MDD), which results in an annual cost of over $200 billion per year. In the perioperative setting, MDD is associated with increased morbidity and mortality. The exact causes of the increase in adverse outcomes are unknown. Major depression affects virtually all major systems in the human body, and most antidepressants affect dopamine, norepinephrine, and serotonin levels or alter their target receptors. Unfortunately, anesthesia and medications used in the perioperative period affect the same neurotransmitters. As a result, patients with MDD are at an increased risk for cardiovascular effects, altered thermoregulation, and postoperative cognitive dysfunction. To determine when to continue or hold antidepressants preoperatively and avoid potential drug interactions, perioperative providers must understand the pharmacological action of antidepressants. This article reviews the pathophysiology of MDD, mechanism of action of antidepressants, and perioperative considerations for patients on antidepressant medications.